Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Promising cancer therapy lutathera tested after liver surgery – study stopped early
Disease control TerminatedThis study looked at whether a radioactive drug called Lutathera, given after surgery to remove liver tumors from neuroendocrine cancer, could help keep the cancer from coming back. It compared Lutathera to standard monitoring (best supportive care) in people with low- or medium-…
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Automated insulin system tested in single patient study
Disease control TerminatedThis study tested whether a smartphone algorithm could automatically control insulin delivery using a continuous glucose monitor and an insulin pump in adults with type 1 diabetes. Only one person enrolled before the study was stopped early. The goal was to see if the system coul…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated May 01, 2026 15:56 UTC